Dr. Erik W. Springer, MD
Gastroenterology (Gastroenterology Physician)
1001 Southpark Dr
Littleton, CO 80120
Who else practices at this address →
Arapahoe County includes primary care (8% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc) (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 274
Licensed in Colorado since 2003, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc)
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
CO license 41455 (first issued 2003; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Adventhealth Littleton Littleton, CO
Medical groups
- Rocky Mountain Gastroenterology Associates, PLLC (36 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 274
- Services billed
- 1,114
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 59 | 57 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 52 | 52 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 49 | 48 |
| Established patient office or other outpatient visit, 30-39 minutes | 47 | 37 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 28 | 28 |
| Biopsy of large bowel using a flexible endoscope | 21 | 21 |
| New patient office or other outpatient visit, 45-59 minutes | 16 | 16 |
| Established patient office or other outpatient visit, 20-29 minutes | 16 | 16 |
| New patient office or other outpatient visit, 30-44 minutes | 15 | 15 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in Littleton, CO | 178 |
| Dicyclomine Hcl Other prescribers in Littleton, CO | 41 |
| Pantoprazole Sodium Other prescribers in Littleton, CO | 37 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Littleton, CO | 33 |
| Dexlansoprazole Dr (dexlansoprazole) Other prescribers in Littleton, CO | 31 |
| Esomeprazole Magnesium Other prescribers in Littleton, CO | 30 |
| Famotidine Other prescribers in Littleton, CO | 27 |
| Linzess (linaclotide) Other prescribers in Littleton, CO | 26 |
| Mesalamine Other prescribers in Littleton, CO | 25 |
| Lansoprazole Other prescribers in Littleton, CO | 24 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 91 payments worth $2,233 in total to this clinician.
| Food and Beverage | $2,233 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $32,260 in research payments for these studies, mostly to the institutions running them.
- An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
E.r. Squibb & Sons, L.l.c. · Terminated · NCT05369832 - A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Takeda Pharmaceuticals U.S.A., Inc. · Recruiting · NCT06581328
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.